Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Naltrexone for Fatigue in POTS
NCT05363514Phase 4Not yet recruiting
- Sponsor
- University of Calgary
- Start
- Jul 2026
- Primary completion
- Jun 2029
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in postural orthostatic tachycardia syndrome (POTS) comparing Low Dose Naltrexone with Placebo (2 arms). Primary endpoint: Fatigue Visual Analogue Scale at 4 months. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
naltrexone
03
Conditions
postural orthostatic tachycardia syndrome (POTS)
Beyond the preview
Go deeper on NCT05363514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05363514.